Russell Investments Group’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9K Buy
2,115
+185
+10% +$2.04K ﹤0.01% 3569
2025
Q4
$15.5K Buy
1,930
+1,115
+137% +$26.1K ﹤0.01% 3695
2025
Q3
$39K Buy
+815
New +$18.1K ﹤0.01% 3369
2021
Q3
Sell
-148
Closed -$73K 3136
2021
Q2
$73K Sell
148
-648
-81% -$316K ﹤0.01% 3093
2021
Q1
$377K Sell
796
-27
-3% -$52.5K ﹤0.01% 2632
2020
Q4
$1.45M Sell
823
-596
-42% -$787K ﹤0.01% 1925
2020
Q3
$1.36M Hold
1,419
﹤0.01% 1918
2020
Q2
$1.65M Buy
1,419
+977
+221% +$883K ﹤0.01% 1757
2020
Q1
$393K Buy
+442
New +$477K ﹤0.01% 2282

Other funds holding KRRO

Russell Investments Group's KRRO Position: Q1 2026 in Review

Russell Investments Group increased its Korro Bio (KRRO) stake by 9.6% in Q1 2026, buying an estimated $2.04K and bringing the position to 2,115 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Russell Investments Group first reported a position in KRRO in Q1 2020 and has held it in 9 quarters since. The position peaked at $1.65M in Q2 2020. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Russell Investments Group held 2,115 shares of Korro Bio worth $23.9K as of Q1 2026.
  • Russell Investments Group bought 185 Korro Bio shares in Q1 2026, an estimated $2.04K.
  • Korro Bio made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3569 holding.
  • Russell Investments Group first reported a position in Korro Bio in Q1 2020 and has held it in 9 quarters since.
  • Russell Investments Group's Korro Bio position peaked at $1.65M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.